Link Between Obsessive-Compulsive Disorder and ApoE Gene Polymorphisms

References

• Alegría M, Frank RG, Hansen HB, Sharfstein JM, Shim RS, Tierney M. Transforming Mental Health And Addiction Services: commentary describes steps to improve outcomes for people with mental illness and addiction in the United States. Health Affairs. 2021;40(2):226–234. doi:10.1377/hlthaff.2020.01472
   PubMed Web of Science ®Google Scholar
• Endres D, von Zedtwitz K, Urbach H, et al. Obsessive-compulsive symptoms in two patients with strategic basal ganglia lesions. Mol Psychiatry. 2023;28(2):528–531. doi:10.1038/s41380-022-01853-8
   PubMed Web of Science ®Google Scholar
• Lamothe H, Schreiweis C, Mondragón-González LS, et al. The Sapap3−/− mouse reconsidered as a comorbid model expressing a spectrum of pathological repetitive behaviours. Transl Psychiatry. 2023;13(1):26. doi:10.1038/s41398-023-02323-7
   PubMed Web of Science ®Google Scholar
• Ruggeri M, Ricci M, Gerace C, Blundo C. Late-onset obsessive-compulsive disorder as the initial manifestation of possible behavioural variant Alzheimer’s disease. Cognitive Neuropsychiatry. 2022;27(1):11–19. doi:10.1080/13546805.2021.1996342
   PubMed Web of Science ®Google Scholar
• Tripathi PN, Srivastava P, Sharma P, et al. Biphenyl-3-oxo-1, 2, 4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg Chem. 2019;85:82–96. doi:10.1016/j.bioorg.2018.12.017
   PubMed Web of Science ®Google Scholar
• Srivastava P, Tripathi PN, Sharma P, et al. Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory. Eur J Med Chem. 2019;163:116–135. doi:10.1016/j.ejmech.2018.11.049
   PubMed Web of Science ®Google Scholar
• Rai SN, Zahra W, Birla H, Singh SS, Singh SP. Commentary: mild endoplasmic reticulum stress ameliorates lpopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial polarization. Front Aging Neurosci. 2018;10:192. doi:10.3389/fnagi.2018.00192
   PubMed Web of Science ®Google Scholar
• Rai SN, Singh C, Singh A, Singh MP, Singh BK. Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimer’s disease. Mol Neurobiol. 2020;57(7):3075–3088. doi:10.1007/s12035-020-01945-y
   PubMed Web of Science ®Google Scholar
• Khiari HM, Achouri A, N.b A, et al. Obsessive–compulsive disorder: a new risk factor for Alzheimer disease? Neurol Sci. 2011;32(5):959–962. doi:10.1007/s10072-011-0480-0
   Web of Science ®Google Scholar
• Dondu A, Sevicok L, Akyol A, Tataroglu C. Is obsessive–compulsive symptomatology a risk factor for Alzheimer-type dementia? Psychiatry Res. 2015;225(3):381–386. doi:10.1016/j.psychres.2014.12.010
   Web of Science ®Google Scholar
• Dadkhah R, Baradaran HR, Almasi-Dooghaee M, Janmohammadi F, Shalbafan M, Heidari A The relationship between the severity of obsessive compulsive disorder (OCD) and Alzheimer’s disease (AD) and frontotemporal dementia (FTD); 2022.
   Google Scholar
• Chen Y, Strickland MR, Soranno A, Holtzman DM. Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron. 2021;109(2):205–221. doi:10.1016/j.neuron.2020.10.008
   PubMed Web of Science ®Google Scholar
• Luo T, Tu YF, Huang S, et al. Alzheimer’s Disease Neuroimaging Initiative (ADNI). The time‐dependent impact of type 2 diabetes mellitus on incident prodromal Alzheimer’s disease: a longitudinal study in 1395 participants. Eur J Neurol. 2023;30(9):2620–2628. doi:10.1111/ene.15868
   Google Scholar
• Nicolini H, Urraca N, Camarena B, et al. Lack of association of apolipoprotein E polymorphism in obsessive-compulsive disorder. CNS Spectrums. 2001;6(12):978–979. doi:10.1017/S1092852900001085
   Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version Patient Edition. SCID-I/P: New York; 2002. 91.
   Google Scholar
• Sertçelik S, Gündoğmuş İ, Gündüz A, Eroğlu MZ, Çipil A, Ergün N. Psychometric properties of the diagnostic interview for adult attention-deficit/hyperactivity disorder 2.0 Turkish version. Psychiatr Ann. 2022;52(2):76–84. doi:10.3928/00485713-20220125-02
   Web of Science ®Google Scholar
• Vogt GS, Avendaño-Ortega M, Schneider SC, Goodman WK, Storch EA. Optimizing obsessive-compulsive symptom measurement with the yale-brown obsessive-compulsive scales—second edition. J Psychiatr Pract. 2022;28(4):294–309. doi:10.1097/PRA.0000000000000640
   Web of Science ®Google Scholar
• Nam SH, Park J, Kim GW, Moon CM, Yang JC. Neural correlates of emotion–cognition interaction during working memory maintenance in obsessive-compulsive disorder: the role of the dorsolateral prefrontal cortex. Psychiatr Clin Psychopharmacol. 2022;32(4):344–350.
   Web of Science ®Google Scholar
• Heinzel S, Kaufmann C, Grützmann R, et al. Polygenic risk for obsessive-compulsive disorder (OCD) predicts brain response during working memory task in OCD, unaffected relatives, and healthy controls. Sci Rep. 2021;11(1):1. doi:10.1038/s41598-021-98333-w
   Web of Science ®Google Scholar
• Segalas C, Alonso P, Labad J, Jaurrieta N, Real E. Jiménez S, et al.Verbal and nonverbal memory processing in patients with obsessive-compulsive disorder: its relationship to clinical variables. Neuropsychology. 2008;22(2):262. doi:10.1037/0894-4105.22.2.262
   Web of Science ®Google Scholar
• Stakias N, Liakos P, Tsiapali E, Gutu M, Koukoulis GN. Lower prevalence of epsilon 4 allele of apolipoprotein E gene in healthy, longer-lived individuals of Hellenic origin. J Gerontol. 2006;61(12):1228–1231. doi:10.1093/gerona/61.12.1228
   Google Scholar
• Li W. Association of APOE E2 and low-density lipoprotein with depressive symptoms in Chinese senile schizophrenia inpatients: a cross-sectional study. Schizophr Res. 2021;23:100193. doi:10.1016/j.scog.2020.100193
   Web of Science ®Google Scholar
• Barker MS, Cosentino SA, Fremont R, Devanand DP, Huey ED. Towards defining the neuroanatomical basis of late-onset psychiatric symptoms. J Geriatric Psychiatry Neurol. 2022;35(6):751–762. doi:10.1177/08919887221090213
   Web of Science ®Google Scholar
• Simón-Martínez V, Laseca-Zaballa G, Lubrini G, et al. Cognitive deficits and clinical symptoms in patients with treatment-refractory obsessive–compulsive disorder: the role of slowness in information processing. Psychiatry Res. 2021;304:11414. doi:10.1016/j.psychres.2021.114143
   Web of Science ®Google Scholar
• Palit A, Roy PK, Saha PK. Role of prospective memory in obsessive compulsive disorder. Indian J Psychol Med. 2022;44(6):586–591. doi:10.1177/02537176221100846
   Google Scholar
• Jalal B, Chamberlain SR, Sahakian BJ. Obsessive‐compulsive disorder: etiology, neuropathology, and cognitive dysfunction. Brain Behav. 2023;13(6):e3000. doi:10.1002/brb3.3000
   Web of Science ®Google Scholar